- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00449995
Confocal Laserscanning Microscopy for Detection of Barretts Esophagus
December 23, 2008 updated by: Technical University of Munich
Confocal Laserscanning Microscopy for Detection of Barretts Esophagus. A Blinded Multi-Center Study.
Four quadrant biopsies in regular ranges is the goldstandard in monitoring this disease.
The ideal situation for the endoscopist is to visualize cellular structures, which implies having microscopic imaging available.
A potential candidate to fill this gap could be confocal fluorescence microscopy (Cellvizio®-GI and Mauna Kea Technologies).
To compare the gold standard with the confocal fluorescence microscopy for detection of metaplastic - or intraepithelial neoplastic changes of barrett-suspicious esophageal mucosa this study has been initiated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
73
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 81675
- 2nd department of the Medical Clinic of the Technical University Munich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age between 18 and 80 years
- regular esophagogastroduodenoscopy for patients with known barrett esophagus (at least stadium C0M1)
- patients presenting for endoscopic mucosectomy with intraepithelial neoplastic changes <1cm
- patients presenting with suspected intraepithelial neoplastic changes
- patients receiving acid suppressive therapy in standard dose for at least 4 weeks
Exclusion Criteria:
- no informed consent
- thrombocytopenia, quick <50%, PTT >50 sec
- patients with coronary heart disease or existent valve plasties
- women with potential pregnancy
- patients with chronic renal failure
- patients with allergies
- patients with chronic obstructive pulmonary disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
diagnostic accuracy of confocal laser scanning microscopy for detection of metaplasia or neoplasia in Barrett´s esophagus
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
inter- and intra observer variability for confocal laser scanning microscopy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alexander Meining, MD, Technical University Munich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2007
Primary Completion (Actual)
July 1, 2008
Study Completion (Actual)
November 1, 2008
Study Registration Dates
First Submitted
February 23, 2007
First Submitted That Met QC Criteria
March 20, 2007
First Posted (Estimate)
March 21, 2007
Study Record Updates
Last Update Posted (Estimate)
December 24, 2008
Last Update Submitted That Met QC Criteria
December 23, 2008
Last Verified
December 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1129/04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.